Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 237 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2778 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VERAP TABLET 120MG 120MG TABLET Actual shortage 2024-04-12 2024-04-26 225017
APO-VERAP TAB 80MG 80MG TABLET Resolved 2018-05-02 2018-07-12 47972
APO-VERAP TAB 80MG 80MG TABLET Resolved 2019-03-13 2019-04-05 78555
APO-VERAP TAB 80MG 80MG TABLET Resolved 2023-02-23 2023-03-02 185462
APO-VERAP TAB 80MG 80MG TABLET Resolved 2023-08-12 2023-09-29 201713
APO-VERAP TAB 80MG 80MG TABLET Resolved 2024-02-02 2024-04-19 218394
APO-VERAP SR 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 255
APO-VERAP SR 180MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-10 2019-12-04 260
APO-VERAP SR 120MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-03-11 2019-12-04 552
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2017-07-25 2018-03-08 16886
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-09-27 2018-03-08 23658
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-03-08 69458
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-12-23 69460
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-18 2019-05-21 82022
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-06-24 86364

Showing 121 to 140 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-02-21 70802
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-07-13 70805
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-08-08 70807
APO-ACETAMINOPHEN 325MG TABLET Discontinued 2018-10-11 2018-10-11 63845
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-09-12 40841
ANTI-NAUSEANT 50MG TABLET Discontinued 2018-02-23 2018-10-25 40844
ACID REDUCER 150MG TABLET Discontinued 2019-01-04 2019-01-04 71210
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
ACETAMINOPHEN TABLETS USP 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71216
ACETAMINOPHEN TABLETS USP 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71219
ACETAMINOPHEN HEADACHE ULTRA RELIEF 500MG 65MG TABLET Discontinued 2019-01-04 2019-01-04 71192
ACETAMINOPHEN CAPLETS 500 MG 500MG TABLET Discontinued 2019-01-04 2019-01-04 71225
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2018-10-25 2018-10-25 65585
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2019-01-04 2019-01-04 71222

Showing 341 to 356 of 356